Generic Drugs Market Research
Discover insightful information you need to be fully informed on the Generic Drugs Market. Reports include data on the Threats and Opportunities of Generic Drugs in today’s market place.
Title ![]() | Date ![]() | Price ![]() |
|---|---|---|
| Irbesartan Pipeline Developer | Mar 2009 | £3,885 |
| Indapamide Pipeline Developer | Mar 2009 | £2,995 |
| Irinotecan Pipeline Developer | Mar 2009 | £3,440 |
| Iron Sucrose Pipeline Developer | Mar 2009 | £3,440 |
| Mirtazapine Pipeline Developer | Mar 2009 | £2,545 |
| Imiquimod Pipeline Developer | Mar 2009 | £3,440 |
| Modafinil Pipeline Developer | Mar 2009 | £2,995 |
| Lamotrigine Pipeline Developer | Mar 2009 | £2,545 |
| Moxidectin (Vet) Pipeline Developer | Mar 2009 | £2,995 |
| Montelukast Pipeline Developer | Mar 2009 | £2,995 |
| Mometasone Pipeline Developer | Mar 2009 | £2,995 |
| Isotretinoin Pipeline Developer | Mar 2009 | £2,995 |
| Itraconazole Pipeline Developer | Mar 2009 | £3,440 |
| Amorolfine Pipeline Developer | Mar 2009 | £2,545 |
| Almotriptan Pipeline Developer | Mar 2009 | £3,440 |
| Amphotericin B Pipeline Developer | Mar 2009 | £4,425 |
| Anastrozole Pipeline Developer | Mar 2009 | £2,995 |
| Aripiprazole Pipeline Developer | Mar 2009 | £3,440 |
| Aliskiren Pipeline Developer | Mar 2009 | £3,440 |
| Alfuzosin Pipeline Developer | Mar 2009 | £2,545 |
| Lacidipine Pipeline Developer | Mar 2009 | £2,545 |
| Lamivudine Pipeline Developer | Mar 2009 | £3,440 |
| Midazolam Pipeline Developer | Mar 2009 | £2,545 |
| Alendronic Acid & Colecalciferol: Extended Country Coverage Pipeline Selector | Mar 2009 | £625 |
| Lansoprazole Pipeline Developer | Mar 2009 | £2,995 |
| Micafungin Pipeline Developer | Mar 2009 | £3,440 |
| Pantoprazole Pipeline Developer | Mar 2009 | £2,995 |
| Paricalcitol Pipeline Developer | Mar 2009 | £2,545 |
| Desloratadine Pipeline Developer | Mar 2009 | £2,995 |
| Moxifloxacin Pipeline Developer | Mar 2009 | £3,885 |
| Lapatinib Pipeline Developer | Mar 2009 | £2,995 |
| Paroxetine Pipeline Developer | Mar 2009 | £2,995 |
| Pegfilgrastim Pipeline Developer | Mar 2009 | £7,145 |
| Pioglitazone Pipeline Developer | Mar 2009 | £3,440 |
| Perindopril Pipeline Developer | Mar 2009 | £2,995 |
| Pergolide Pipeline Developer | Mar 2009 | £2,545 |
| Penciclovir Pipeline Developer | Mar 2009 | £3,440 |
| Levetiracetam Pipeline Developer | Mar 2009 | £2,995 |
| Latanoprost Pipeline Developer | Mar 2009 | £2,545 |
| Meloxicam Pipeline Developer | Mar 2009 | £2,545 |
| Meloxicam (Vet) Pipeline Developer | Mar 2009 | £2,545 |
| Memantine Pipeline Developer | Mar 2009 | £2,100 |
| Meropenem Pipeline Developer | Mar 2009 | £3,440 |
| Losartan Pipeline Developer | Mar 2009 | £3,885 |
| Linezolid Pipeline Developer | Mar 2009 | £3,440 |
| Lercanidipine Pipeline Developer | Mar 2009 | £2,995 |
| Tramadol & Paracetamol: Core Country Coverage Pipeline Selector | Mar 2009 | £270 |
| Levocetirizine Pipeline Developer | Mar 2009 | £2,995 |
| Levofloxacin Pipeline Developer | Mar 2009 | £3,885 |
| Armodafinil Pipeline Developer | Mar 2009 | £2,995 |
| Atorvastatin Pipeline Developer | Mar 2009 | £3,440 |
| Citalopram Pipeline Developer | Mar 2009 | £2,995 |
| Cisatracurium Pipeline Developer | Mar 2009 | £2,545 |
| Cladribine Pipeline Developer | Mar 2009 | £2,545 |
| Clarithromycin Pipeline Developer | Mar 2009 | £2,995 |
| Clopidogrel Pipeline Developer | Mar 2009 | £2,995 |
| Ciprofloxacin Pipeline Developer | Mar 2009 | £3,440 |
| Ciclosporin (Vet) Pipeline Developer | Mar 2009 | £3,440 |
| Cefuroxime Pipeline Developer | Mar 2009 | £2,545 |
| Celecoxib Pipeline Developer | Mar 2009 | £3,885 |
| Cetuximab Pipeline Developer | Mar 2009 | £4,425 |
| Ciclosporin Pipeline Developer | Mar 2009 | £3,440 |
| Darbepoetin alfa Pipeline Developer | Mar 2009 | £4,425 |
| Cefditoren Pipeline Developer | Mar 2009 | £3,440 |
| Brinzolamide Pipeline Developer | Mar 2009 | £2,995 |
| Budesonide Pipeline Developer | Mar 2009 | £3,440 |
| Buprenorphine Pipeline Developer | Mar 2009 | £2,995 |
| Cabergoline Pipeline Developer | Mar 2009 | £2,100 |
| Brimonidine Pipeline Developer | Mar 2009 | £2,995 |
| Bosentan Pipeline Developer | Mar 2009 | £2,995 |
| Caspofungin Pipeline Developer | Mar 2009 | £3,440 |
| Bimatoprost Pipeline Developer | Mar 2009 | £2,995 |
| Bisoprolol Pipeline Developer | Mar 2009 | £2,545 |
| Bortezomib Pipeline Developer | Mar 2009 | £3,440 |
| Ceftiofur (Vet) Pipeline Developer | Mar 2009 | £3,440 |
| Cefprozil Pipeline Developer | Mar 2009 | £2,545 |
| Alendronic Acid & Colecalciferol: Core Country Coverage Pipeline Selector | Mar 2009 | £270 |
| Alendronic Acid Pipeline Developer | Mar 2009 | £2,995 |
| Doxorubicin Pipeline Developer | Mar 2009 | £3,885 |
| Dorzolamide Pipeline Developer | Mar 2009 | £2,995 |
| Telmisartan Pipeline Developer | Mar 2009 | £3,885 |
| Alendronic Acid & Colecalciferol Pipeline Developer | Mar 2009 | £3,440 |
| Barnidipine Pipeline Developer | Mar 2009 | £3,440 |
| Ivermectin & Praziquantel (Vet): Core Country Coverage Pipeline Selector | Mar 2009 | £270 |
| Atovaquone Pipeline Developer | Mar 2009 | £2,545 |
| Azelastine Pipeline Developer | Mar 2009 | £3,440 |
| Azithromycin Pipeline Developer | Mar 2009 | £2,995 |
| Letrozole Pipeline Developer | Mar 2009 | £2,995 |
| Ivermectin & Praziquantel (Vet): Extended Country Coverage Pipeline Selector | Mar 2009 | £625 |
| Adapalene Pipeline Developer | Mar 2009 | £2,995 |
| Adefovir Pipeline Developer | Mar 2009 | £3,440 |
| Bevacizumab Pipeline Developer | Mar 2009 | £4,425 |
| Bicalutamide Pipeline Developer | Mar 2009 | £2,545 |
| Adalimumab Pipeline Developer | Mar 2009 | £4,425 |
| Acitretin Pipeline Developer | Mar 2009 | £2,545 |
| Tramadol & Paracetamol: Extended Country Coverage Pipeline Selector | Mar 2009 | £625 |
| Leflunomide Pipeline Developer | Mar 2009 | £2,545 |
| Abacavir Pipeline Developer | Mar 2009 | £3,440 |
| Acarbose Pipeline Developer | Mar 2009 | £2,995 |
| Calcipotriol Pipeline Developer | Mar 2009 | £2,995 |
Filter Results by
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us


first
previous












